Normally, blood cells are made in the bone marrow in an orderly and controlled way. In people with AML, this process gets out of control and many abnormal leukaemia cells are made. Acute myeloid leukaemia (AML) is a devastating form of blood cancer that mainly affects people over 60 years old.1 For older patients who receive chemotherapy, the median survival is less than a year. Even though AML is considered rare, it accounts for around 18,860 new cases and 10,000 deaths in the US each year and is the most frequent cause of leukaemia-related deaths.Only 1 in 3 (36%) of people have heard of Acute Myeloid Leukaemia (AML), reveals survey of 2,520 people from across Europe.
Symptoms: looking pale and feeling tired and breathless, which is due to anaemia caused by a lack of red blood cells, having more infections than usual, because of a lack of healthy white blood cells, unusual bleeding caused by too few platelets - this may include bruising (bruises may appear without any apparent injury), heavy periods in women, bleeding gums, nosebleeds and blood spots or rashes on the skin (petechiae)
Therapeutic aspects: Your treatment will be planned by a team of specialists who will meet to discuss and agree on the plan of treatment they feel is best for you. One or more haematologists, Specialist nurses, who give information and support, Pathologists, who advise on the type and extent of the leukaemia A clinical oncologist, who specialises in radiotherapy and chemotherapy.